Rachel King, CEO of GlycoMimetics and a BIO Board member

GlycoMimetics, Rachel King discusses the prevalence of sickle cell disease and urgency to find treatments. She discusses the importance of raising awareness for the disease as June 19th is World Sickle Cell Day. As head of a Maryland-based company and a BIO Board Member, King also has been instrumental in organizing the upcoming BIO International Convention, coming to Washington, DC on June 27-30.